Načítá se...
Amantadine for treatment of fatigue in Guillain‐Barré syndrome: a randomised, double blind, placebo controlled, crossover trial
OBJECTIVE: Fatigue is a major complaint in patients with immune mediated polyneuropathies. Despite apparently good physical recovery after Guillain‐Barré syndrome (GBS), many patients remain restricted in daily and social activities, and have a decreased quality of life. In this trial, the effect of...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2117395/ https://ncbi.nlm.nih.gov/pubmed/16361594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.2004.046227 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|